Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-23-000331
Filing Date
2023-03-30
Accepted
2023-03-30 19:41:54
Documents
1
Period of Report
2023-03-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1537
  Complete submission text file 0001753926-23-000331.txt   2922
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Issuer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Cohen Daniel R (Reporting) CIK: 0001971611 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41575 | Film No.: 23782380